A hypothesis for endogenous opioid peptides in uraemic pruritus: Role of enkephalin [3]

Nephrology Dialysis Transplantation

Volumn 16, Issue 9, 2001, Pages 1953-1954

  Odou, P ^a,b   Azar, R ^a   Luyckx, M ^c   Brunet, C ^c   Dine, T ^c  

^a Dunkerque Hospital   (France)

^b Laboratory of Bacteriology   (France)

^c Pharmacology Pharmacokinetic and Clinical Pharmacy Department   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; DYNORPHIN; ENKEPHALIN; NALTREXONE; OPIATE; OPIATE ANTAGONIST; PROOPIOMELANOCORTIN; PROTEIN PRECURSOR;

ADULT; AGED; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEMODIALYSIS PATIENT; HUMAN; HYPOTHESIS; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; SCORING SYSTEM; TABLET FORMULATION; UREMIA;

EID: 0034838985     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.9.1953     Document Type: Letter

References (8)

1. Endogenous opioids accumulate in plasma in rat model of acute cholestasis
2. A controlled trial of naloxone infusion for the pruritus of chronic cholestasis
3. Randomised crossover trial of naltrexone in uraemic pruritus
4. The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two peptide recognition cores
5. Plasma immunoreactive β-endorphin is elevated in uremia
6. Serum bile acids and pruritus in hemodialysis patients
7. Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study
8. Uremic pruritus is not related to beta-endorphin serum levels in haemodialysis